![Athena Countouriotis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 30/06/2026
Athena Countouriotis forma parte del consejo de administración de Iovance Biotherapeutics, Inc. y NuMedii, Inc. y de Passage Bio, Inc. y es presidenta, consejera delegada y directora de Turning Point Therapeutics, Inc. Anteriormente, el Dr. Countouriotis fue Director de Investigación Clínica Global de Oncología en Bristol Myers Squibb Co, Director Médico y Vicepresidente Senior de Halozyme Therapeutics, Inc, Director Médico y Vicepresidente Senior de Adverum Biotechnologies, Inc, Director Médico Asociado de CTI BioPharma Corp y Director Médico de Ambit Biosciences Corp. El Dr. Countouriotis se doctoró en la Facultad de Medicina de la Universidad de Tufts y se licenció en la Universidad de California en Los Ángeles.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/06/2026 | 21.040 ( 0,01 % ) | 1 M $ | 30/06/2026 | |
PASSAGE BIO, INC. 0,03 % | 19/05/2026 | 945 ( 0,03 % ) | 4 612 $ | 30/06/2026 |
| 16/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Director/Miembro de la Junta | 10/06/2019 |
| PASSAGE BIO, INC. | Director/Miembro de la Junta | 01/02/2020 |
| BIOMARIN PHARMACEUTICAL INC. | Director/Miembro de la Junta | 27/12/2023 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Director Ejecutivo | - |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Presidente | 12/10/2022 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Presidente | 12/09/2022 |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies | Director/Miembro de la Junta | 20/06/2018 |
Leal Therapeutics, Inc.
 Leal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops neuro-metabolic therapies for CNS disorders | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Director/Miembro de la Junta | 24/01/2020 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 17 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies | Commercial Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
Leal Therapeutics, Inc.
Leal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops neuro-metabolic therapies for CNS disorders | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
